RGC NASDAQ
Regencell Bioscience Holdings Limited
1W: +10.5%
1M: +8.1%
3M: +21.6%
YTD: -66.8%
1Y: -56.9%
3Y: +1497.8%
5Y: +749.7%
$6.82
+0.49 (+7.74%)
Weekly Expected Move ±10.5%
$5
$6
$7
$8
$8
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+22.2% ▲
Capital Expenditures
$153K
-2740.3% ▼
5Y CAGR: +5.3%
Free Cash Flow
-$3M
+18.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$542K
-138.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$7M | -$6M | -$4M | -$4M |
| Depreciation & Amort. | $26K | $604K | $770K | $746K | $393K |
| Stock-Based Comp. | $0 | $3M | $930K | $449K | $0 |
| Change in Working Capital | $553K | -$1M | -$509K | -$585K | $19K |
| Other Non-Cash Items | $0 | -$159K | -$283K | -$248K | $59K |
| Operating Cash Flow | -$767K | -$5M | -$5M | -$4M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$781K | -$27K | -$5K | -$153K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$5M | -$32M |
| Investment Sales | $0 | $0 | $0 | $10M | $35M |
| Other Investing | $0 | -$10M | $86K | $0 | $0 |
| Investing Cash Flow | $0 | -$11M | $59K | $5M | $3M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $440K | $22M | $135K | $102K | $0 |
| Financing Cash Flow | $440K | $22M | $135K | $102K | $0 |
| Net Change in Cash | -$328K | $6M | -$5M | $1M | -$542K |
| Cash End of Period | $59K | $6M | $2M | $3M | $2M |
| Free Cash Flow | -$767K | -$6M | -$5M | -$4M | -$3M |